Search

everythinglearnresearchcommunity

for

Search:↓

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Liposomes show promise for delivering CRISPR for gene editing but face challenges like delivery efficiency and safety concerns.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Harlequin mutant mice have hair loss due to low AIF protein levels and retroviral element activity.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The HPV type 11 region activates hair-specific gene expression in mice.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.